Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case
Apple Inc.'s (NASDAQ: AAPL) smartwatches could face an import ban as a U.S.
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Monday, there were a few notable insider trades.
New Prospective Study Finds That Masimo SpHb Noninvasive And Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management In Patients Undergoing Major Surgery
Masimo (NASDAQ:MASI) today announced the findings of a prospective, double-blinded, randomized, controlled trial published in the Journal of the College of Physicians and Surgeons Pakistan. In the study, Dr.
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
Masimo Sets the Record Straight On Bylaw Amendments, Responds To Politan Capital Management’s Complaint
Masimo (NASDAQ:MASI) today issued the following statement in response to the complaint filed by Politan Capital Management ("Politan") in the Delaware Court of Chancery (the "Lawsuit"):
We believe
Politan Capital Management Filed Verified Complaint Seeking Relief To Declare Amendments To Certain Of Masimo Corp’s Corporate Bylaws Unenforceable
Masimo's Recent Bylaw Amendments Following Politan's Engagement Effectively Preclude Stockholders from Nominating Director Candidates and Are Without Precedent
Politan Hopes for Constructive Engagement with Masimo Yet Now Needs to Defend Stockholder Rights in Court
Jefferies Initiates Coverage On Masimo with Buy Rating, Announces Price Target of $180
Jefferies analyst Matthew Taylor initiates coverage on Masimo (NASDAQ:MASI) with a Buy rating and announces Price Target of $180.